Cyclodextrins—New Fields of Application and Research for the Benefit of Mankind and the Planet

Dear Colleagues,

Cyclodextrins have brought us significant progress, offering us more efficient medicines, innovative vaccines and eco-friendly processes for soil and water cleaning and gold mining. Looking ahead to the future, this Special Issue presents the current knowledge of the significant potential of cyclodextrins to anticipate how cyclodextrins are poised to continue fostering development in key topics.

Personalised medicines, vaccines and advanced medical therapies will continue to be a significant area of research, and one which has special relevance to this Special Issue. Topics include the development of targeted drug delivery systems using sophisticated cyclodextrin-based nanoparticles, as well as gene therapy and mRNA nucleic acid delivery in both medicines and vaccines. Papers covering prospect developments in neuromedicine, immunomodulation/infectious disease treatments and the role of cyclodextrins in personalised medicine approaches are also welcome.

In the realm of smart materials and nanotechnology, besides the vast potential of CD-MOFS, new responsive and adaptive materials based on cyclodextrins are emerging. Advanced biomaterials for tissue engineering and regenerative medicine, as well as nano-platforms for diagnostics and theranostics, can be explored and presented in this forum.

Environmental sustainability is another key topic. Enhanced water purification, soil amelioration for weather-resilient crops, and precious metal recovery using green chemistry are processes that benefit from the use of cyclodextrins and are gradually making their way into sustainable industrial applications. Energy applications include cyclodextrin-based materials for energy storage and conversion, as well as solar energy harvesting and photovoltaic technologies.

Dr. Susana Santos Braga
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.